Work

Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers

Year: 2016

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-016-3800-5

Authors: Shani Paluch-Shimon, Eitan Friedman, Raanan Berger, Moshe Papa, Maya Dadiani, Neil Friedman, Moshe Shabtai, Dov Zippel, Mordechai Gutman, Talia Golan, Ady Yosepovich, Raphael Catane, Tami Modiano, Bella Kaufman

Institutions: Tel Aviv University, Sheba Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2461958762

FWCI: 3.469

Cites: 36

Cited by: 59

Related to: 10